| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.004 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.007 |